Bayes TR. An essay towards solving a problem in the doctrine of chances Philosophical Transactions of the Royal Society 53 370-418

Berry DA.  "Bayesian clinical trials." Nature Reviews Drug Discovery. January 2006; 5(1): 27-36. (PubMed)

Carlin BP, TA Louis. Bayes and Empirical Bayes Methods for Data Analysis. 2nd Edition, London: Chapman & Hall, 2000.

Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J.Health Econ. 1999 Jun;18(3):341-364.

Eisenstein EL, Collins R, Cracknell BS, et al. Sensible approaches for reducing clinical trial costs. Clin Trials. 2008;5(1):75-84. (PubMed)

Gelman A and J Hill.  Data Analysis Using Regression and Multilevel Hierarchical Models.  Cambridge: Cambridge University Press, 2007.

Getz KA, Wenger J, Campo RA, Seguine ES, Kaitin KI. Assessing the impact of protocol design changes on clinical trial performance. Am J Ther. Sep-Oct 2008;15(5):450-457. (PubMed)

Gilks WR, S Richardson, DG Spiegelhalter.  Markov Chain Monte Carlo in Practice.  London: Chapman & Hall, 1996.

Karanicolas PJ, Montori VM, Devereaux PJ, Schunemann H, Guyatt GH. A new 'mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol. May 2009;62(5):479-484. (PubMed)

Luce BR, Claxton K. Redefining the analytical approach to pharmacoeconomics. Health Econ. 1999 May;8(3):187-189.

Luce BR, Kramer JM, Goodman SN, Connor J, Tunis S, Whicher D, Schwartz JS.  Rethinking Randomized Clinical Trials for Comparative Effectivness Research: The Need for Transformational Change. Annals of Internal Medicine. 4 August 2009;151(3). (Available Online)

Luce BR, Paramore CL, Parasuraman B, Liljas B, de Lissovoy G, Weiss KB. “Can Managed Care Successfully Partner with Manufacturers to Generate Comparative Effectiveness Research Evidence? Two Case Studies.” American Journal of Managed Care. March 2008; 14(3): 140-156. (PubMed)

O'Hagan A, Luce BR. "A Primer on Bayesian Statistics in Health Economics and Outcomes Research." 2003. (Free PDF Version)

O'Hagan A, Stevens JW, Montmartin J. Bayesian cost-effectiveness analysis from clinical trial data. Stat.Med. 2001 Mar 15;20(5):733-753.

Robert CP.  The Bayesian Choice. 2 ed.  Springer, 2001.

Skrepnek GH. The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis. Pharmacoeconomics 2007;25(8):649-664.

Spiegelhalter DJ. Bayesian Approaches to Clinical Trials and Health-Care Evaluation (Statistics in Practice). Wiley, 2004.

Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Bayesian methods in health technology assessment: a review. Health Technol.Assess. 2000;4(38):1-130.

Stangl DK.  Bridging the gap between statistical analysis and decision making in public health research.  Statist Med 2005; 24: 503-511.

Tanner MA.  Tools for Statistical Inference.  Methods for the Exploration of Posterior Distributions and Likelihood Functions.  3d ed.  Springer, 1996.

Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. May 2009;62(5):464-475. (PubMed)

Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624-1632. (PubMed)

Wilensky GR. Developing a center for comparative effectiveness information. Health Aff (Millwood). Nov-Dec 2006;25(6):w572-585. (PubMed)

Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390. (PubMed)